World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, 



Dr. Pushpa Chhangani*


Anal fistula is a common problem that causes substantial morbidity in persons who are otherwise healthy. It is one in which a patient experiences pain, discharge and un-comfortness etc. Owing to the numerous surgical complications while treating the disease, the Ksharsutra therapy came as a breakthrough and Aragvadhadi sutra was accepted as the standardized one. This study was conducted to evaluate the effectiveness of Aragvadhadi sutra in the management of Bhagandara (Fistula-in-ano). A total of 40 patients were included in this study on inclusion criteria and divided into two equal groups. Trial group treated with Aragvadhadi sutra and control group treated with Standard Ksharsutra. Assessment was made on pain and objective (Nadi Chedan Kala) parameters. Observations were made before the treatment and on every 7th day of the therapy until complete cutting of the track. This study reveals that in group A the patients had Grade II, III and IV severity of pain and in group B the pain grade was observed as Grade I, II and III. In Group A (Standard Ksharsutra) the Nadi Chedan Kala was 0.91 cm/week and in Group B (Aragvadhadi sutra) the Nadi Chedan Kala was 0.84 cm/week. The study showed that the trial drug Aragvadhadi sutra was as good as the standard Ksharsutra in the treatment of Bhagandara.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here